SlideShare a Scribd company logo
An Overview of Diabetes
Sid McNulty
Consultant Physician &
Endocrinologist
Constructivism and Experiential
learning and the brain
Sensory
Integrative
Making sense
Integrative
Planning
‘Motor’
(plus verbal)
Concrete experience
Active reflection
Abstract
conceptualisation
Active experimentation
Neuronal networks
Tap into and build on what the learner already
knows
ACEi actions
K+ sparing
Diuretic
Antihypertensive
Postural hypotension
Insulin action Hypoglycaemia
Addison’s
Lack of RAAS drive
Lack of insulin antagonism
Cushing’s opposite of
Addison’s
and therefore opposite of:
Insulin and diuretics, and
therefore….
Blockage of RAAS
Diagnosis of Diabetes
WHO (adopted in UK 6/00):
Symptoms of hyperglycaemia plus 1 blood
Random/2 hr plasma gluc > 11.1 mmol/l, or
Fasting plasma glucose > 7.0 mmol/l
In the absence of symptoms, there must be 2
plasma glucose results in the diabetic range on
separate days.
Diagnostic dilemma
Sensitivity: positives identified as positive
Specificity: negatives identified as negative
100% specific
Over 10m long
Over 15,000 mph
Over 6,000 Km high
No false alarms
Lots of false -ve
100% sensitive
Over 1m long
Over 10mph
Off the ground
Don’t miss a strike
Lots of false +ve
Lethal Disease X
Affects 1 in 10,000
100% fatal – horrible and painful death
Fantastic test for it 99% (99% sensitive ie picks
up disease as disease, and 99% specific ie
picks up normal as normal)
You have the test
1 week later the results
You are positive
What is your probability you have disease?
What do you do?
Please stand up
Condition
Positive Negative
Test
Result
Positive True +ve False +ve +ve predictive
value
TP/TP+FP
Negative False -ve True –ve -ve predictive
value
TN/TN+FN
Sensitivity 99%
TP/TP+FN x100
Specificity 99%
TN/TN+FP x
100
A ‘Good’ Test
A ‘Good’ Test?
The Devil is in the detail!
Condition
Positive Negative
Test
Result
Positive True +ve False +ve +ve predictive
value
TP/TP+FP
Negative False -ve True –ve -ve predictive
value
TN/TN+FN
Sensitivity 99%
TP/TP+FN x100
Specificity 99%
TN/TN+FP x
100
A ‘Good’ Test
What tests means
Sensitivity: about the disease…the people you identify
with the disease/total number with the disease
(TP/TP+FN)…if you have disease, you test positive
Specificity: about the disease…the people you identify
without the disease/total number without the disease
(TN/TN+FP)… if you don’t have disease you test
negative
Positive predictive value: about the test…the number of
people you test positive with the disease/total number
you test positive (TP/TP+FP)… if you test positive,
likelihood you have disease
Negative predictive value: about the test…the number of
people you test negative without the disease/total
number you test negative (TN/TN+FN)… if you test
negative, likelihood you don’t have the disease
Gedankenversuch
Test: being called mags to diagnose
being a woman
Male Female
True positive
False
negative
False positive
True
negative
What being called mags means
Sensitivity (disease): if you’re a woman, how likely
is it you’ll be called mags (low 1%)
Specificity (disease): if you’re not a woman, how
likely is it you’ll not be called mags (v high
99.99%)
Positive predictive value (test): if you’re called
mags, how likely are you to be a woman (high
99%)
Negative predictive value (test): if you’re not
called mags, how likely you’re not a woman
(poor 50%)
Lethal Disease X
Affects 1 in 10,000
100% fatal – horrible and painful death
Fantastic test for it 99% (99% sensitive ie picks
up disease as disease, and 99% specific ie
picks up normal as normal)
You have the test
1 week later the results
You are positive
What is your probability you have disease?
What do you do?
Please stand up, again
One million people
1 in 10,000 with disease 1 in 100 with false +ve
1 in 10,000 with
disease and +ve
test
ie 100 people
1 in 100 with +ve
test and no disease
ie 10,000 people
One million people
How many have disease?
1 in 10,000
100 people
How many would test positive?
1 in 100
10,000
If positive do you have disease?
What is the positive predictive value
TP/TP+FP: 100/10,100
ie 1 in 100 chance!
Therefore – even the best test should be interpreted with
clinical data, and should only be asked for in the right
people (ETT ECGs, VQs etc etc)
What tests means
Sensitivity: about the disease…the people you identify
with the disease/total number with the disease
(TP/TP+FN)…if you have disease, you test positive
Specificity: about the disease…the people you identify
without the disease/total number without the disease
(TN/TN+FP)… if you don’t have disease you test
negative
Positive predictive value: about the test…the number of
people you test positive with the disease/total number
you test positive (TP/TP+FP)… if you test positive,
likelihood you have disease
Negative predictive value: about the test…the number of
people you test negative without the disease/total
number you test negative (TN/TN+FN)… if you test
negative, likelihood you don’t have the disease
Incidence of Diabetes
The incidence is increasing steeply
World diabetic population is estimated to
reach 221 million people by 2010 (double
the number in 1994).
Over 1.4 million people in the United
Kingdom (3% of the pop) have diagnosed
diabetes mellitus, with perhaps another
million as yet undiagnosed.
Amos AF et al.The rising global burden of diabetes...Diabetic
Med 1997;14(suppl 5):S1-85.
Types of diabetes
Type 1 (IDDM)
Absolute insulin
deficiency
ß-cell failure
Young, thin
Prone to DKA
Type 2 (NIDDM)
Relative insulin
deficiency
Insulin resistance
Old, ↑BMI (kg/m2
)
Usually on tablets or diet
(can be on insulin)
No DKA : instead HONK
Insulin balance with age T1DM
0
20
40
60
80
100
120
insulin req
insulin T1
‘Event’
Obesity and T2DM
Obesity
Inactivity
Insulin resistance
Hyperglycaemia
Micro- and macro-vascular
complications
Hypertension
Dyslipidaemia
Endothelial dysfunction
Prothombotic state
The Progress to T2DM
Wt 70 kg
Requires 60 U
Panc Res 200 U
Level: 60 U
Normal
Wt 100 kg
Requires 150 U
PR 200 U
Level: 150 U
‘Normal’
Wt 70 kg
Requires 60 U
Panc Res 100 U
Level: 60 U
Normal
Wt 100 kg
Requires 150 U
Panc Res 100 U
Level: 100 U
DM & Hyperinsulin
NORMAL T2DM
12 v 121 v 1210 units?
8 v 81 v 810 units/hr?
50 v 501 v 5010 units/50ml?
1010 units Actrapid at 100 mls/hr?
Insulin balance with age T2DM
0
20
40
60
80
100
120
insulin T1
insulin T2
Insulin balance with age T2DM
0
20
40
60
80
100
120
insulin req0
insulin T1
insulin T2
Why worry with diabetic in-patients
Avoid emergencies:
Main aim of your Mx
Plus tighten peri-operative glucose control
Diabetic emergencies
Hypoglycaemia
Hyperglycaemia
DKA: Type 1
HHS/HONK: Type 2
Hypoglycaemia
BMs 2-4
Autonomic symptoms: Sympathetic
Sweaty, agitated, nausea, shaky, pale, hungry
BMs 0-2
Neuroglycopenic:
Confusion, aggression, agitation, coma,
hemiparesis etc
Mechanism of Normoglycaemia
β cell
Proinsulin
Insulin C Peptide
↓ Glucose
Pancreas
Pancreas
Glucagon Glycogen Liver
↑ Glucose
Mechanism of Hypoglycaemia
β cell
Proinsulin
Insulin C Peptide
↓ Glucose
Pancreas
Pancreas
Glucagon Glycogen Liver
↑ Glucose
1.Sulphonylureas
3.Exogenous
4.Lack of antagonist
(cortisol etc)
5.IGF 2
6.Excess use
2.Excess
7.Lack of
8.Lack of
Treatment of Hypo
Treatment:
IV glucose 50ml 50%
IM glucagon 1 mg
?Treat cause
steroids (Addison’s, NICTH)
surgery (Insulinoma, NICTH)
Diazoxide & high dose BFZ (Paliative Insulinoma)
DSN review/ Psych review
Presentation & definition of DKA
Young, thin, T1DM
Poly-uria, -dypsia, weight loss (passing sugar water)
SOB (kussmal - blowing off CO2 to ↓pH),
dehydrated, ↓ BP, vasodilated, drowsy
Raised blood glucose (>15 mmol/L)
Metabolic acidosis:
pH <7.3, Bicarb <15 mmol/L
Ketosis: ketostix > ++
Mechanism of DKA
Intercurrent illness
Increased counter-regulatory
hormones (Cats and cortisol)
Severe insulin deficiency
Hyperglycaemia
Mechanism of DKA
Hormone-sensitive lipase
TriglycerideNon-esterified fatty acids
Acetoacetate
3-HydroxybutyrateAcetone
Glycerol
+
Insulin
-
Mechanism of DKA
Intercurrent illness
Increased counter-regulatory
hormones (Cats and cortisol)
Severe insulin deficiency
Hormone-sensitive lipase
TriglycerideNon-esterified fatty acids
Acetoacetate
3-HydroxybutyrateAcetone
Glycerol
+ +
+
Hyperglycaemia
Mechanism of DKA
Hyperglycaemia Ketone bodies
Osmotic
diuresis Vomiting Acidosis
Electrolyte
depletion
Dehydration Vasodilatation
Hypotension Hypothermia
Management of DKA General
NG tube
Reduced consciousness
Gastroparesis
IV access
? Central line only if indicated
Catheter
?UTI may have precipitated DKA
Dehydrated and immunosuppressed
Serious risk of introducing ascending infection
Therefore only if not PU’d in 3 hours
Remove / treat precipitator (low threshold for Abs)
?Heparin (coma or Osmolality >350 mOsm/L)
Management DKA Specific
T1DM
Acute decompensation
pH <7.3, Bicarb <15, Ketosis, Gluc >15
IV insulin 0.1 unit/kg/hr = 6-8 units/hr
IV fluids 5 Ltr/24hr
? Abs (WCC/Temp mean little)
No Bicarb
Inform your senior
13th
May 2010
Died July 1997
Retired last year and
still facing 12 charges!
HyperOsmotic NonKetotic Coma (AKA)
Hyperglycaemic HyperOsmolar Syndrome
Presentation & Definition
In Type 2 DM
Longer Hx -poly-uria/dypsia
Dehydration, ↓BP, unwell
High RBG (usually >>30 mmol/L)
Osmolality >350
(Na+
+ K+
) x2 + Urea + Glucose = Osmol
Management of HHS Summary
T2DM, older, co-morbidity, more sick
Osmol > 350 mmol/Ltr
Gluc usually >>30 mmol/Ltr
Same general management as DKA
IV insulin 0.1 units/kg/hr = 6-8 units/hour
IV fluids 3-5 Ltr/24hr
Go more gentle!
?Full heparin dose
Abs, MI screen etc
Inform your senior
GKI/Alberti (to give insulin to T1DM)
15 units Actrapid
500 ml 10% Dextrose
10 mmol KCl
80-100ml/hour
If BMs high add another 5 units (and on)
If BMs low add 5 units less (and on)
Check K 1 hour before bag change
Restart sc insulin 1/2 hour before eating
Complications & Diabetes
Microvascular v Macrovascular
‘KNIVES’
K - kidneys
N - nerves
I - impotence, infection
V – vascular (IHD, CVA, PVD)
E - eyes
S - skin infections
Macrovascular risk factors
Male
Age
Family History
Other Vascular Disease:
CVA, TIA
LVH
Diabetes
Hypertension
Lipids:
↑Chol, ↑LDL, ↓HDL, ↑ TGs
Smoking
Obesity
Exercise
Diabetic complications
Prevention of complications
Risk reduction – relative versus absolute
Risk elimination
Residual risk
Intervention studies - Drug X
Reduces total chol 70%
Reduces LDL 50%
Increases HDL 10%
Would you take it?
Surrogate markers
Losing weight reduces chol
Losing weight by losing legs
Reduces relative risk of MI 50%
Would you take it?
Relative risk reduction
RR↓ 50%
RR↓ 50%
RR↓ 50%
Risk of AE Relative versus absolute risk
RR↓ 50%
Absolute risk reduction
Absolute risk reduction
Absolute risk reduction
Lies, damn lies and statistics
6/49 x 5/48 x 4/47 x 3/46 x 2/45 x 1/44 =
720/10,068,347,520 =
1 in 13,983,816
Increase your relative risk by 100%
To 1 in 6,991,908
Absolute risk increase 1 in 13 million
Reduce your relative risk by 50%
1 in 27,967,632
Absolute risk reduction 1 in 13 million
Numbers Needed to Treat….
100 patients
10 events
100 patients
5 events
Relative risk reduction 50%
Treat 100 people, 5 events prevented, therefore treat 20 to prevent 1
This maybe all that we can offer you
1000 patients
10 events
1000 patients
5 events
Relative risk reduction 50%
Treat 1000 people, 5 events prevented, therefore treat 200 to prevent 1
Intervention studies - Drug X
Reduces total chol 70%
Reduces LDL 50%
Increases HDL 10%
Would you take it?
Surrogate markers
Losing weight reduces chol
Losing weight by losing legs
Reduces relative risk of MI 50%
Would you take it?
Serious adverse event 1% per year
Would you take it?
What does risk reduction mean?
What was not going
to happen
When does this not
happen
What did happen
in spite of
intervention..
When did you
cause this?
What didn’t happen
with
intervention…
When does this not
happen
When did you
prevent this?
RR reduction 50% with 20% side effects
What was not going
to happen
Plus SE
Primum non nocere
First do no harm!
What did happen
in spite of
intervention..
When did you
cause this?
Plus SE
What didn’t
happen with
intervention…
When did you
prevent this?
Plus SE
Maximilien François Marie Isidore de Ro
(May 6, 1758–July 28, 1794),
On ne peut pas faire
d'omelette sans casser des
oeufs
You can't make an omelette
without breaking eggs
Primum non nocere
Risk of crossing the road
Park cars
Eyes closed
Heavy traffic
Run out
Pedestrian crossing
Wait for green man
Look both ways
Walk briskly don’t
run
No guarantee to be or not be run over
NB you do get to the other side.
The prevention of accident happens in
definite time frame
Prevention of macrovascular
complications
Primary prevention
All T2DM & most T1DM (10y risk <15%)
Tight glycaemic control (~UKPDS & DCCT)
Tight BP control (UKPDS)
Tight lipid management
Aspirin, ACE I/AT2A, smoking, BMI
Secondary prevention
Hx of CVA, MI, IHD, PVD, Amputation
Glycaemia in T2DM
HbA1c 2/12 marker (area under the curve)
Mean 5.4%, SD 0.4%
i.e. normal <6.2
HbA1c <7.5 <6.5
Normality
Mean
1 SD
2 SDs
3 SDs
68%
95%
99%
HbA1c: mean 5.4%, SD 0.4%
5.4%
6.2%
68%
95%
99.5%
7.0%4.6%
2.5% ‘normal
population’
0.25%
Oral Hypoglycaemics
Metformin (if BMI >24)
500 - 1000mg b.d - t.d.s
Side effects - GI….lactic acidosis
Contraindications - CRF, CCF, hepatic problems
No weight gain, no hypos
Gliclazide (if BMI <22)
40 - 320mg per day (od - bd)
Side effects weight gain & hypos
Glitazones (pioglitazone > rosiglitazone), acarbose
etc
Hypoglycaemics
Incretins – Exanatide, gliptins
Insulins:
long v short
free v pre-mixed
human v pork v analogue
?CSII etc
Combination with OHA
Normal person
0
2
4
6
8
10
12
14
16
18
1 3 5 7 9 11 13 15 17 19 21 23
Isulin
Glusose
BD Mix
0
5
10
15
20
25
30
35
40
short
long
7am 6pm
Breakfast
Lunch
Dinner
Snack
Basal Bolus
0
5
10
15
20
25
30
35
1
3
5
7
9
11
13
15
17
19
21
23
Basal
Bolus
am short
Lunch short
Dinner short
Evening background
Titrating Insulin-
BD mix
BM reading Insulin
7 am Nocte long
Noon Mane short
6 pm Mane long
10 pm Nocte short
Titrating Insulin-
Basal Bolus
BM reading Insulin
7 am Nocte basal
Noon Mane short
6 pm Noon short
10 pm Supper short
Lipid lowering
Diet/lifestyle/co-morbid/smoking
CVS equivalent (or CVS risk >15%@10 yr)
LDL/Total Chol (>2.0/4.0) - Statins
HDL/Trigs (<1, >2.2) - ? Fibrates
Statins - Simva 40, Atova 40-80mg nocte
good for total and LDL chol
Fibrates - Fenofibrate micro 267mg mane
good for trigs and HDL
Nicotinic acid - good for trigs and HDL
Ezetimibe - add on therapy, Omacor - post MI
ABCD tool
Anti-hypertensives
ACE I/AT2A
Ramipril 2.5 - 10mg, Irebesartan 150 - 300mg
Partic if: CCF, IHD, MI, nephropathy, CVA
CI: pregnant, renovascular disease (watch Creat)
Thiazide diuretics (low dose!) - BFZ 2.5 mg o.d
β blockers - atenolol 50mg
Partic if MI, IHD, CCF
CCB - Amolidipine 5-10mg o.d
α blockers - Doxazosin XL 4-16mg (BPH)
Central acting etc
Microvascular Complications
Retinopathy
Nephropathy
Neuropathy
Erectile dysfunction
Prevention of microvascular
complications
Primary prevention
Tighten control:
Glycaemia, BP, Lipids
Aspirin, ACE I, Anti Obesity
Secondary prevention
Catch & Treat early (as above, laser Rx etc)
Therefore screen for them
Funduscopy, feet inspection, urine & blood tests
Annual Screen
HbA1c/Lipids/Creat/BP/Wt
Alb:Creat Ratio
Feet - pulses, sensation (10g MF), ulcers
Eyes - dilated funduscopy, VAs
Kidneys - BP/ACR/Creat
Smoking status
Mx T2DM Conclusions
Lifestyle: Smoking, Diet, Exercise & Weight
Annual screen for complications
Glycaemic control (UKPDS Metformin > Glic)
CVS Risk Calculation (>15%) v Equiv
Lipid control
LFD, Statin, ?Fibrates
BP control
ACE I, ATII, Diuretics, β Blocker, CCB, other
Other drug Rx:
Aspirin,?anti obesity,?anti smoking, ?HRT
Questions?

More Related Content

What's hot

Nephrotic syndrome case presentation
Nephrotic syndrome case presentationNephrotic syndrome case presentation
Nephrotic syndrome case presentation
binaya tamang
 
Scenarios Part 1 For PLAB 2
Scenarios Part 1 For PLAB 2Scenarios Part 1 For PLAB 2
Scenarios Part 1 For PLAB 2
usmlematerialsnet
 
Bp.dr.leen
Bp.dr.leenBp.dr.leen
Bp.dr.leen
LeenDoya
 
Module 3 VHF Prevention and Control Training CASE DEFINITIONS TRIAGE AND MANA...
Module 3 VHF Prevention and Control Training CASE DEFINITIONS TRIAGE AND MANA...Module 3 VHF Prevention and Control Training CASE DEFINITIONS TRIAGE AND MANA...
Module 3 VHF Prevention and Control Training CASE DEFINITIONS TRIAGE AND MANA...
tryphine mutyasera
 
Điều trị Hội chứng thận hư - Viêm cầu thận cấp - 2019 - Đại học Y dược TPHCM
Điều trị Hội chứng thận hư - Viêm cầu thận cấp - 2019 - Đại học Y dược TPHCMĐiều trị Hội chứng thận hư - Viêm cầu thận cấp - 2019 - Đại học Y dược TPHCM
Điều trị Hội chứng thận hư - Viêm cầu thận cấp - 2019 - Đại học Y dược TPHCM
Update Y học
 
Anti-hypertensives in Pregnancy
Anti-hypertensives in PregnancyAnti-hypertensives in Pregnancy
Anti-hypertensives in Pregnancy
Dr. Aisha M Elbareg
 
Lupus nephritis with pregnancy
Lupus nephritis with pregnancyLupus nephritis with pregnancy
Lupus nephritis with pregnancy
BSMMU
 

What's hot (7)

Nephrotic syndrome case presentation
Nephrotic syndrome case presentationNephrotic syndrome case presentation
Nephrotic syndrome case presentation
 
Scenarios Part 1 For PLAB 2
Scenarios Part 1 For PLAB 2Scenarios Part 1 For PLAB 2
Scenarios Part 1 For PLAB 2
 
Bp.dr.leen
Bp.dr.leenBp.dr.leen
Bp.dr.leen
 
Module 3 VHF Prevention and Control Training CASE DEFINITIONS TRIAGE AND MANA...
Module 3 VHF Prevention and Control Training CASE DEFINITIONS TRIAGE AND MANA...Module 3 VHF Prevention and Control Training CASE DEFINITIONS TRIAGE AND MANA...
Module 3 VHF Prevention and Control Training CASE DEFINITIONS TRIAGE AND MANA...
 
Điều trị Hội chứng thận hư - Viêm cầu thận cấp - 2019 - Đại học Y dược TPHCM
Điều trị Hội chứng thận hư - Viêm cầu thận cấp - 2019 - Đại học Y dược TPHCMĐiều trị Hội chứng thận hư - Viêm cầu thận cấp - 2019 - Đại học Y dược TPHCM
Điều trị Hội chứng thận hư - Viêm cầu thận cấp - 2019 - Đại học Y dược TPHCM
 
Anti-hypertensives in Pregnancy
Anti-hypertensives in PregnancyAnti-hypertensives in Pregnancy
Anti-hypertensives in Pregnancy
 
Lupus nephritis with pregnancy
Lupus nephritis with pregnancyLupus nephritis with pregnancy
Lupus nephritis with pregnancy
 

Similar to Diabetes Overview by Dr McNulty

Disorders of the Adrenal Glands
Disorders of the Adrenal GlandsDisorders of the Adrenal Glands
Disorders of the Adrenal Glands
Patrick Carter
 
Pregnancy related hypertensive disorders
Pregnancy related hypertensive disordersPregnancy related hypertensive disorders
Pregnancy related hypertensive disorders
Ayub Medical College
 
pregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdf
pregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdfpregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdf
pregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdf
GichanaElvis
 
Hypertensive Dirders of Pregnancy By Dr Zahid Ullah
Hypertensive Dirders of Pregnancy By Dr Zahid UllahHypertensive Dirders of Pregnancy By Dr Zahid Ullah
Hypertensive Dirders of Pregnancy By Dr Zahid Ullah
Ayub Medical College
 
Antitubercular Agents
Antitubercular AgentsAntitubercular Agents
Antitubercular Agents
girlie
 
dengue fever murag final na why title need to be long.pptx
dengue fever murag final na why title need to be long.pptxdengue fever murag final na why title need to be long.pptx
dengue fever murag final na why title need to be long.pptx
kaydeear
 
Endocrine Potpourri.pptx
Endocrine Potpourri.pptxEndocrine Potpourri.pptx
Endocrine Potpourri.pptx
WarunKumar7
 
HTN DM for 3rd Yr Clerkship Family Med
HTN DM for 3rd Yr Clerkship Family MedHTN DM for 3rd Yr Clerkship Family Med
HTN DM for 3rd Yr Clerkship Family Med
mdmendoz
 
Common Lab Investigations in pregnancy with reference to Anaemia, Leukocytosi...
Common Lab Investigations in pregnancy with reference to Anaemia, Leukocytosi...Common Lab Investigations in pregnancy with reference to Anaemia, Leukocytosi...
Common Lab Investigations in pregnancy with reference to Anaemia, Leukocytosi...
DrNisheethOza
 
hypertensive_disorders.ppt
hypertensive_disorders.ppthypertensive_disorders.ppt
hypertensive_disorders.ppt
Addis53
 
PEDIATRIC ANAPHYLAXIS
PEDIATRIC ANAPHYLAXISPEDIATRIC ANAPHYLAXIS
PEDIATRIC ANAPHYLAXIS
Phil Adit R
 
Oncological Emergencies comep OCT 2010
Oncological Emergencies  comep OCT  2010Oncological Emergencies  comep OCT  2010
Oncological Emergencies comep OCT 2010
NES
 
SLE Case Presentation
 SLE Case Presentation SLE Case Presentation
SLE Case Presentation
Vishwa Jayasinghe
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
shabeel pn
 
Diabetes Mellitus management in OPD
Diabetes Mellitus management in OPDDiabetes Mellitus management in OPD
Diabetes Mellitus management in OPD
nium
 
Hypoadrenalism
HypoadrenalismHypoadrenalism
Hypoadrenalism
guest77cb9c
 
Gluteal abscess with diabetes mellitus and diabetic ketoacidosis (2)
Gluteal abscess with diabetes mellitus and diabetic ketoacidosis (2)Gluteal abscess with diabetes mellitus and diabetic ketoacidosis (2)
Gluteal abscess with diabetes mellitus and diabetic ketoacidosis (2)
Goutham Kondeti
 
Ht12 - GP education seminar
Ht12 - GP education seminar Ht12 - GP education seminar
Ht12 - GP education seminar
alistair begg
 
Ultimate Comprehensive ABSITE Study Guide1.docx
Ultimate Comprehensive ABSITE Study Guide1.docxUltimate Comprehensive ABSITE Study Guide1.docx
Ultimate Comprehensive ABSITE Study Guide1.docx
SanielleKarlaGarciaL
 
National Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A session
National Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A sessionNational Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A session
National Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A session
Graham Atherton
 

Similar to Diabetes Overview by Dr McNulty (20)

Disorders of the Adrenal Glands
Disorders of the Adrenal GlandsDisorders of the Adrenal Glands
Disorders of the Adrenal Glands
 
Pregnancy related hypertensive disorders
Pregnancy related hypertensive disordersPregnancy related hypertensive disorders
Pregnancy related hypertensive disorders
 
pregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdf
pregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdfpregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdf
pregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdf
 
Hypertensive Dirders of Pregnancy By Dr Zahid Ullah
Hypertensive Dirders of Pregnancy By Dr Zahid UllahHypertensive Dirders of Pregnancy By Dr Zahid Ullah
Hypertensive Dirders of Pregnancy By Dr Zahid Ullah
 
Antitubercular Agents
Antitubercular AgentsAntitubercular Agents
Antitubercular Agents
 
dengue fever murag final na why title need to be long.pptx
dengue fever murag final na why title need to be long.pptxdengue fever murag final na why title need to be long.pptx
dengue fever murag final na why title need to be long.pptx
 
Endocrine Potpourri.pptx
Endocrine Potpourri.pptxEndocrine Potpourri.pptx
Endocrine Potpourri.pptx
 
HTN DM for 3rd Yr Clerkship Family Med
HTN DM for 3rd Yr Clerkship Family MedHTN DM for 3rd Yr Clerkship Family Med
HTN DM for 3rd Yr Clerkship Family Med
 
Common Lab Investigations in pregnancy with reference to Anaemia, Leukocytosi...
Common Lab Investigations in pregnancy with reference to Anaemia, Leukocytosi...Common Lab Investigations in pregnancy with reference to Anaemia, Leukocytosi...
Common Lab Investigations in pregnancy with reference to Anaemia, Leukocytosi...
 
hypertensive_disorders.ppt
hypertensive_disorders.ppthypertensive_disorders.ppt
hypertensive_disorders.ppt
 
PEDIATRIC ANAPHYLAXIS
PEDIATRIC ANAPHYLAXISPEDIATRIC ANAPHYLAXIS
PEDIATRIC ANAPHYLAXIS
 
Oncological Emergencies comep OCT 2010
Oncological Emergencies  comep OCT  2010Oncological Emergencies  comep OCT  2010
Oncological Emergencies comep OCT 2010
 
SLE Case Presentation
 SLE Case Presentation SLE Case Presentation
SLE Case Presentation
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Diabetes Mellitus management in OPD
Diabetes Mellitus management in OPDDiabetes Mellitus management in OPD
Diabetes Mellitus management in OPD
 
Hypoadrenalism
HypoadrenalismHypoadrenalism
Hypoadrenalism
 
Gluteal abscess with diabetes mellitus and diabetic ketoacidosis (2)
Gluteal abscess with diabetes mellitus and diabetic ketoacidosis (2)Gluteal abscess with diabetes mellitus and diabetic ketoacidosis (2)
Gluteal abscess with diabetes mellitus and diabetic ketoacidosis (2)
 
Ht12 - GP education seminar
Ht12 - GP education seminar Ht12 - GP education seminar
Ht12 - GP education seminar
 
Ultimate Comprehensive ABSITE Study Guide1.docx
Ultimate Comprehensive ABSITE Study Guide1.docxUltimate Comprehensive ABSITE Study Guide1.docx
Ultimate Comprehensive ABSITE Study Guide1.docx
 
National Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A session
National Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A sessionNational Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A session
National Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A session
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 

Diabetes Overview by Dr McNulty

  • 1. An Overview of Diabetes Sid McNulty Consultant Physician & Endocrinologist
  • 2. Constructivism and Experiential learning and the brain Sensory Integrative Making sense Integrative Planning ‘Motor’ (plus verbal) Concrete experience Active reflection Abstract conceptualisation Active experimentation
  • 3. Neuronal networks Tap into and build on what the learner already knows ACEi actions K+ sparing Diuretic Antihypertensive Postural hypotension Insulin action Hypoglycaemia Addison’s Lack of RAAS drive Lack of insulin antagonism Cushing’s opposite of Addison’s and therefore opposite of: Insulin and diuretics, and therefore…. Blockage of RAAS
  • 4. Diagnosis of Diabetes WHO (adopted in UK 6/00): Symptoms of hyperglycaemia plus 1 blood Random/2 hr plasma gluc > 11.1 mmol/l, or Fasting plasma glucose > 7.0 mmol/l In the absence of symptoms, there must be 2 plasma glucose results in the diabetic range on separate days.
  • 5. Diagnostic dilemma Sensitivity: positives identified as positive Specificity: negatives identified as negative 100% specific Over 10m long Over 15,000 mph Over 6,000 Km high No false alarms Lots of false -ve 100% sensitive Over 1m long Over 10mph Off the ground Don’t miss a strike Lots of false +ve
  • 6. Lethal Disease X Affects 1 in 10,000 100% fatal – horrible and painful death Fantastic test for it 99% (99% sensitive ie picks up disease as disease, and 99% specific ie picks up normal as normal) You have the test 1 week later the results You are positive What is your probability you have disease? What do you do?
  • 8. Condition Positive Negative Test Result Positive True +ve False +ve +ve predictive value TP/TP+FP Negative False -ve True –ve -ve predictive value TN/TN+FN Sensitivity 99% TP/TP+FN x100 Specificity 99% TN/TN+FP x 100 A ‘Good’ Test
  • 10. The Devil is in the detail!
  • 11. Condition Positive Negative Test Result Positive True +ve False +ve +ve predictive value TP/TP+FP Negative False -ve True –ve -ve predictive value TN/TN+FN Sensitivity 99% TP/TP+FN x100 Specificity 99% TN/TN+FP x 100 A ‘Good’ Test
  • 12. What tests means Sensitivity: about the disease…the people you identify with the disease/total number with the disease (TP/TP+FN)…if you have disease, you test positive Specificity: about the disease…the people you identify without the disease/total number without the disease (TN/TN+FP)… if you don’t have disease you test negative Positive predictive value: about the test…the number of people you test positive with the disease/total number you test positive (TP/TP+FP)… if you test positive, likelihood you have disease Negative predictive value: about the test…the number of people you test negative without the disease/total number you test negative (TN/TN+FN)… if you test negative, likelihood you don’t have the disease
  • 14. Test: being called mags to diagnose being a woman Male Female True positive False negative False positive True negative
  • 15. What being called mags means Sensitivity (disease): if you’re a woman, how likely is it you’ll be called mags (low 1%) Specificity (disease): if you’re not a woman, how likely is it you’ll not be called mags (v high 99.99%) Positive predictive value (test): if you’re called mags, how likely are you to be a woman (high 99%) Negative predictive value (test): if you’re not called mags, how likely you’re not a woman (poor 50%)
  • 16. Lethal Disease X Affects 1 in 10,000 100% fatal – horrible and painful death Fantastic test for it 99% (99% sensitive ie picks up disease as disease, and 99% specific ie picks up normal as normal) You have the test 1 week later the results You are positive What is your probability you have disease? What do you do?
  • 18. One million people 1 in 10,000 with disease 1 in 100 with false +ve 1 in 10,000 with disease and +ve test ie 100 people 1 in 100 with +ve test and no disease ie 10,000 people
  • 19. One million people How many have disease? 1 in 10,000 100 people How many would test positive? 1 in 100 10,000 If positive do you have disease? What is the positive predictive value TP/TP+FP: 100/10,100 ie 1 in 100 chance! Therefore – even the best test should be interpreted with clinical data, and should only be asked for in the right people (ETT ECGs, VQs etc etc)
  • 20. What tests means Sensitivity: about the disease…the people you identify with the disease/total number with the disease (TP/TP+FN)…if you have disease, you test positive Specificity: about the disease…the people you identify without the disease/total number without the disease (TN/TN+FP)… if you don’t have disease you test negative Positive predictive value: about the test…the number of people you test positive with the disease/total number you test positive (TP/TP+FP)… if you test positive, likelihood you have disease Negative predictive value: about the test…the number of people you test negative without the disease/total number you test negative (TN/TN+FN)… if you test negative, likelihood you don’t have the disease
  • 21. Incidence of Diabetes The incidence is increasing steeply World diabetic population is estimated to reach 221 million people by 2010 (double the number in 1994). Over 1.4 million people in the United Kingdom (3% of the pop) have diagnosed diabetes mellitus, with perhaps another million as yet undiagnosed. Amos AF et al.The rising global burden of diabetes...Diabetic Med 1997;14(suppl 5):S1-85.
  • 22. Types of diabetes Type 1 (IDDM) Absolute insulin deficiency ß-cell failure Young, thin Prone to DKA Type 2 (NIDDM) Relative insulin deficiency Insulin resistance Old, ↑BMI (kg/m2 ) Usually on tablets or diet (can be on insulin) No DKA : instead HONK
  • 23. Insulin balance with age T1DM 0 20 40 60 80 100 120 insulin req insulin T1 ‘Event’
  • 24. Obesity and T2DM Obesity Inactivity Insulin resistance Hyperglycaemia Micro- and macro-vascular complications Hypertension Dyslipidaemia Endothelial dysfunction Prothombotic state
  • 25. The Progress to T2DM Wt 70 kg Requires 60 U Panc Res 200 U Level: 60 U Normal Wt 100 kg Requires 150 U PR 200 U Level: 150 U ‘Normal’ Wt 70 kg Requires 60 U Panc Res 100 U Level: 60 U Normal Wt 100 kg Requires 150 U Panc Res 100 U Level: 100 U DM & Hyperinsulin NORMAL T2DM
  • 26. 12 v 121 v 1210 units? 8 v 81 v 810 units/hr? 50 v 501 v 5010 units/50ml? 1010 units Actrapid at 100 mls/hr?
  • 27. Insulin balance with age T2DM 0 20 40 60 80 100 120 insulin T1 insulin T2
  • 28. Insulin balance with age T2DM 0 20 40 60 80 100 120 insulin req0 insulin T1 insulin T2
  • 29. Why worry with diabetic in-patients Avoid emergencies: Main aim of your Mx Plus tighten peri-operative glucose control
  • 31. Hypoglycaemia BMs 2-4 Autonomic symptoms: Sympathetic Sweaty, agitated, nausea, shaky, pale, hungry BMs 0-2 Neuroglycopenic: Confusion, aggression, agitation, coma, hemiparesis etc
  • 32. Mechanism of Normoglycaemia β cell Proinsulin Insulin C Peptide ↓ Glucose Pancreas Pancreas Glucagon Glycogen Liver ↑ Glucose
  • 33. Mechanism of Hypoglycaemia β cell Proinsulin Insulin C Peptide ↓ Glucose Pancreas Pancreas Glucagon Glycogen Liver ↑ Glucose 1.Sulphonylureas 3.Exogenous 4.Lack of antagonist (cortisol etc) 5.IGF 2 6.Excess use 2.Excess 7.Lack of 8.Lack of
  • 34. Treatment of Hypo Treatment: IV glucose 50ml 50% IM glucagon 1 mg ?Treat cause steroids (Addison’s, NICTH) surgery (Insulinoma, NICTH) Diazoxide & high dose BFZ (Paliative Insulinoma) DSN review/ Psych review
  • 35. Presentation & definition of DKA Young, thin, T1DM Poly-uria, -dypsia, weight loss (passing sugar water) SOB (kussmal - blowing off CO2 to ↓pH), dehydrated, ↓ BP, vasodilated, drowsy Raised blood glucose (>15 mmol/L) Metabolic acidosis: pH <7.3, Bicarb <15 mmol/L Ketosis: ketostix > ++
  • 36. Mechanism of DKA Intercurrent illness Increased counter-regulatory hormones (Cats and cortisol) Severe insulin deficiency Hyperglycaemia
  • 37. Mechanism of DKA Hormone-sensitive lipase TriglycerideNon-esterified fatty acids Acetoacetate 3-HydroxybutyrateAcetone Glycerol + Insulin -
  • 38. Mechanism of DKA Intercurrent illness Increased counter-regulatory hormones (Cats and cortisol) Severe insulin deficiency Hormone-sensitive lipase TriglycerideNon-esterified fatty acids Acetoacetate 3-HydroxybutyrateAcetone Glycerol + + + Hyperglycaemia
  • 39. Mechanism of DKA Hyperglycaemia Ketone bodies Osmotic diuresis Vomiting Acidosis Electrolyte depletion Dehydration Vasodilatation Hypotension Hypothermia
  • 40. Management of DKA General NG tube Reduced consciousness Gastroparesis IV access ? Central line only if indicated Catheter ?UTI may have precipitated DKA Dehydrated and immunosuppressed Serious risk of introducing ascending infection Therefore only if not PU’d in 3 hours Remove / treat precipitator (low threshold for Abs) ?Heparin (coma or Osmolality >350 mOsm/L)
  • 41. Management DKA Specific T1DM Acute decompensation pH <7.3, Bicarb <15, Ketosis, Gluc >15 IV insulin 0.1 unit/kg/hr = 6-8 units/hr IV fluids 5 Ltr/24hr ? Abs (WCC/Temp mean little) No Bicarb Inform your senior
  • 42. 13th May 2010 Died July 1997 Retired last year and still facing 12 charges!
  • 43. HyperOsmotic NonKetotic Coma (AKA) Hyperglycaemic HyperOsmolar Syndrome Presentation & Definition In Type 2 DM Longer Hx -poly-uria/dypsia Dehydration, ↓BP, unwell High RBG (usually >>30 mmol/L) Osmolality >350 (Na+ + K+ ) x2 + Urea + Glucose = Osmol
  • 44. Management of HHS Summary T2DM, older, co-morbidity, more sick Osmol > 350 mmol/Ltr Gluc usually >>30 mmol/Ltr Same general management as DKA IV insulin 0.1 units/kg/hr = 6-8 units/hour IV fluids 3-5 Ltr/24hr Go more gentle! ?Full heparin dose Abs, MI screen etc Inform your senior
  • 45. GKI/Alberti (to give insulin to T1DM) 15 units Actrapid 500 ml 10% Dextrose 10 mmol KCl 80-100ml/hour If BMs high add another 5 units (and on) If BMs low add 5 units less (and on) Check K 1 hour before bag change Restart sc insulin 1/2 hour before eating
  • 46. Complications & Diabetes Microvascular v Macrovascular ‘KNIVES’ K - kidneys N - nerves I - impotence, infection V – vascular (IHD, CVA, PVD) E - eyes S - skin infections
  • 47. Macrovascular risk factors Male Age Family History Other Vascular Disease: CVA, TIA LVH Diabetes Hypertension Lipids: ↑Chol, ↑LDL, ↓HDL, ↑ TGs Smoking Obesity Exercise
  • 48. Diabetic complications Prevention of complications Risk reduction – relative versus absolute Risk elimination Residual risk
  • 49. Intervention studies - Drug X Reduces total chol 70% Reduces LDL 50% Increases HDL 10% Would you take it? Surrogate markers Losing weight reduces chol Losing weight by losing legs Reduces relative risk of MI 50% Would you take it?
  • 50. Relative risk reduction RR↓ 50% RR↓ 50% RR↓ 50%
  • 51. Risk of AE Relative versus absolute risk RR↓ 50% Absolute risk reduction Absolute risk reduction Absolute risk reduction
  • 52. Lies, damn lies and statistics 6/49 x 5/48 x 4/47 x 3/46 x 2/45 x 1/44 = 720/10,068,347,520 = 1 in 13,983,816 Increase your relative risk by 100% To 1 in 6,991,908 Absolute risk increase 1 in 13 million Reduce your relative risk by 50% 1 in 27,967,632 Absolute risk reduction 1 in 13 million
  • 53. Numbers Needed to Treat…. 100 patients 10 events 100 patients 5 events Relative risk reduction 50% Treat 100 people, 5 events prevented, therefore treat 20 to prevent 1
  • 54. This maybe all that we can offer you 1000 patients 10 events 1000 patients 5 events Relative risk reduction 50% Treat 1000 people, 5 events prevented, therefore treat 200 to prevent 1
  • 55. Intervention studies - Drug X Reduces total chol 70% Reduces LDL 50% Increases HDL 10% Would you take it? Surrogate markers Losing weight reduces chol Losing weight by losing legs Reduces relative risk of MI 50% Would you take it? Serious adverse event 1% per year Would you take it?
  • 56. What does risk reduction mean? What was not going to happen When does this not happen What did happen in spite of intervention.. When did you cause this? What didn’t happen with intervention… When does this not happen When did you prevent this?
  • 57. RR reduction 50% with 20% side effects What was not going to happen Plus SE Primum non nocere First do no harm! What did happen in spite of intervention.. When did you cause this? Plus SE What didn’t happen with intervention… When did you prevent this? Plus SE
  • 58. Maximilien François Marie Isidore de Ro (May 6, 1758–July 28, 1794), On ne peut pas faire d'omelette sans casser des oeufs You can't make an omelette without breaking eggs Primum non nocere
  • 59. Risk of crossing the road Park cars Eyes closed Heavy traffic Run out Pedestrian crossing Wait for green man Look both ways Walk briskly don’t run No guarantee to be or not be run over NB you do get to the other side. The prevention of accident happens in definite time frame
  • 60. Prevention of macrovascular complications Primary prevention All T2DM & most T1DM (10y risk <15%) Tight glycaemic control (~UKPDS & DCCT) Tight BP control (UKPDS) Tight lipid management Aspirin, ACE I/AT2A, smoking, BMI Secondary prevention Hx of CVA, MI, IHD, PVD, Amputation
  • 61. Glycaemia in T2DM HbA1c 2/12 marker (area under the curve) Mean 5.4%, SD 0.4% i.e. normal <6.2 HbA1c <7.5 <6.5
  • 62. Normality Mean 1 SD 2 SDs 3 SDs 68% 95% 99%
  • 63. HbA1c: mean 5.4%, SD 0.4% 5.4% 6.2% 68% 95% 99.5% 7.0%4.6% 2.5% ‘normal population’ 0.25%
  • 64. Oral Hypoglycaemics Metformin (if BMI >24) 500 - 1000mg b.d - t.d.s Side effects - GI….lactic acidosis Contraindications - CRF, CCF, hepatic problems No weight gain, no hypos Gliclazide (if BMI <22) 40 - 320mg per day (od - bd) Side effects weight gain & hypos Glitazones (pioglitazone > rosiglitazone), acarbose etc
  • 65. Hypoglycaemics Incretins – Exanatide, gliptins Insulins: long v short free v pre-mixed human v pork v analogue ?CSII etc Combination with OHA
  • 66. Normal person 0 2 4 6 8 10 12 14 16 18 1 3 5 7 9 11 13 15 17 19 21 23 Isulin Glusose
  • 69. Titrating Insulin- BD mix BM reading Insulin 7 am Nocte long Noon Mane short 6 pm Mane long 10 pm Nocte short
  • 70. Titrating Insulin- Basal Bolus BM reading Insulin 7 am Nocte basal Noon Mane short 6 pm Noon short 10 pm Supper short
  • 71. Lipid lowering Diet/lifestyle/co-morbid/smoking CVS equivalent (or CVS risk >15%@10 yr) LDL/Total Chol (>2.0/4.0) - Statins HDL/Trigs (<1, >2.2) - ? Fibrates Statins - Simva 40, Atova 40-80mg nocte good for total and LDL chol Fibrates - Fenofibrate micro 267mg mane good for trigs and HDL Nicotinic acid - good for trigs and HDL Ezetimibe - add on therapy, Omacor - post MI
  • 73. Anti-hypertensives ACE I/AT2A Ramipril 2.5 - 10mg, Irebesartan 150 - 300mg Partic if: CCF, IHD, MI, nephropathy, CVA CI: pregnant, renovascular disease (watch Creat) Thiazide diuretics (low dose!) - BFZ 2.5 mg o.d β blockers - atenolol 50mg Partic if MI, IHD, CCF CCB - Amolidipine 5-10mg o.d α blockers - Doxazosin XL 4-16mg (BPH) Central acting etc
  • 75. Prevention of microvascular complications Primary prevention Tighten control: Glycaemia, BP, Lipids Aspirin, ACE I, Anti Obesity Secondary prevention Catch & Treat early (as above, laser Rx etc) Therefore screen for them Funduscopy, feet inspection, urine & blood tests
  • 76. Annual Screen HbA1c/Lipids/Creat/BP/Wt Alb:Creat Ratio Feet - pulses, sensation (10g MF), ulcers Eyes - dilated funduscopy, VAs Kidneys - BP/ACR/Creat Smoking status
  • 77. Mx T2DM Conclusions Lifestyle: Smoking, Diet, Exercise & Weight Annual screen for complications Glycaemic control (UKPDS Metformin > Glic) CVS Risk Calculation (>15%) v Equiv Lipid control LFD, Statin, ?Fibrates BP control ACE I, ATII, Diuretics, β Blocker, CCB, other Other drug Rx: Aspirin,?anti obesity,?anti smoking, ?HRT